Spitalul Clinic De Psihiatrie Prof.Dr.Alexandru Obregia

At Spitalul Clinic De Psihiatrie Prof.Dr.Alexandru Obregia, research in psychiatry and mental disorders focuses strongly on bipolar I disorder and major depressive disorder. These studies are designed to evaluate new approaches for controlling mania, easing depressive symptoms, and helping prevent relapse in people whose symptoms remain difficult to manage.

• Acute mania and manic episodes in bipolar I disorder
• Major depressive disorder, including anhedonia and insomnia-related symptoms
• Testing new treatments to improve mood stability and reduce relapse
• Evaluating add-on therapies for people who do not respond well to standard care

This work reflects a broad effort to improve day-to-day functioning and long-term symptom control in common but serious psychiatric conditions.

A major part of the site’s clinical trial activity centers on schizophrenia and psychosis, including symptoms linked to Alzheimer’s disease. The research aims to better understand hallucinations, delusions, negative symptoms, and cognitive difficulties, while also assessing the safety and effectiveness of newer treatment options.

• Schizophrenia in adults and adolescents
• Psychosis associated with Alzheimer’s disease
• Hallucinations, delusions, and negative symptoms
• Studying new therapies and long-term treatment benefit

These trials support efforts to improve symptom relief and daily functioning for people living with complex psychotic disorders.

The site also contributes to research on Alzheimer’s disease, with attention to behavioral and psychological symptoms such as agitation and psychosis. Studies in this area are exploring whether new treatments can help reduce distressing symptoms and support cognition and overall functioning in people with mild to moderate disease.

• Alzheimer’s disease with agitation
• Alzheimer’s disease with psychosis, hallucinations, or delusions
• Testing therapies aimed at behavioral symptom control
• Exploring effects on thinking skills and global functioning

This research is especially relevant for patients and families seeking better ways to manage challenging neuropsychiatric symptoms.

Clinical trials at this hospital also cover nervous system diseases, including multiple sclerosis, epilepsy, and migraine. Much of this work focuses on children and adolescents, with studies designed to improve treatment options, assess long-term safety, and support better control of neurological symptoms.

• Multiple sclerosis, including relapsing-remitting and pediatric forms
• Childhood absence epilepsy and juvenile absence epilepsy
• Migraine in children and adolescents
• Evaluating effectiveness, safety, and long-term tolerability of new therapies

This portfolio shows a strong interest in both pediatric neurology and chronic neurological diseases that can affect learning, development, and quality of life.